ASBP — Aspire Biopharma Holdings, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1847345 ·
Last close
$8.32
Market Cap
$11.67M
52W High
$18.76
52W Low
$0.11
ADV30
33,310
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 63,104 | -30,086 | -2,448,804 | -1,268,142 | 13,540,544 | 12,167,136 | 1,782,723 |
| Mar 2026 | 28,353 | 5,750 | -1,646,169 | -3,222,892 | 7,117,147 | 5,857,024 | 3,248,684 |
| Dec 2025 | 4,261 | -1,000 | -1,849,424 | -4,707,734 | 1,312,166 | 1,003,904 | 7,688,495 |
| Sep 2025 | 1,941 | 884 | -1,145,497 | -1,850,493 | 2,403,129 | 1,948,271 | 13,870,407 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,210,482
Investing CF
$0
Financing CF
$10,720,963
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-621.45
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-30,480,973
Inventory
$369,974
Receivables
$0
ST Investments
—
EBIT TTM
$-1,925,753
Pretax Income TTM
$-11,762,412
Interest Exp TTM
$9,836,659
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$97,659
EBITDA
—
Free Cash Flow
$7,431,185
Enterprise Value
$540,032
Total Cash
$12,167,136
Total Debt
$0
Shares Out
1,402,557
Trailing EPS
$-6.65
Book Value
$9.08
ROE
-1032.1%
ROA
60.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,202 | -19,351,291 | -24,480,848 | 1,312,166 | 7,688,495 | -6,376,329 | -4,923,488 |
| Dec 2024 | 0 | -1,210,871 | -1,309,872 | 147,989 | 1,688,077 | -1,540,088 | -265,186 |
| Dec 2023 | 0 | -1,340,168 | 4,464,079 | 46,174 | 534,035 | -487,861 | 11,136 |
| Dec 2022 | 0 | -596,491 | -597,117 | 22,538 | 151,328 | -128,790 | -142,905 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KPRX | KIORA PHARMACEUTICALS INC | $11.64M | $2.63 | — |
| MBRX | Moleculin Biotech, Inc. | $11.73M | $0.60 | — |
| PHIO | Phio Pharmaceuticals Corp. | $11.73M | $1.01 | — |
| CALC | CalciMedica, Inc. | $11.95M | $1.75 | — |
| SCNX | Scienture Holdings, Inc. | $11.37M | $0.28 | — |
News headlines (Yahoo Finance, 1h cache)
Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program
2026-09-09 12:30 · Yahoo
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.
2026-09-08 13:00 · Yahoo
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
2026-08-11 02:31 · Yahoo
OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD
2026-07-10 10:33 · Yahoo
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th
2026-06-17 14:57 · Yahoo
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?
2026-06-12 14:14 · Yahoo
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Reven
2026-06-12 12:30 · Yahoo
Aspire Biopharma Issues Shareholder Letter
2026-05-28 12:30 · Yahoo
Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program
2026-05-13 17:46 · Yahoo
Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP)
2026-06-12 14:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.